SCHEMBL17044980

SCHEMBL17044980

CC(C)C[C@H](C(=O)N(C(=O)[C@@H]1CCCN1)c1ccc(-c2cc3cc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](CC(C)C)N(C)C)ccc3[nH]2)cc1)N(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB8 P28062 2/20 0.36
PFKFB2 O60825 1/20 0.34
PFKFB1 P16118 1/20 0.34
PFKFB3 Q16875 1/20 0.34
STAT3 P40763 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
KCNH2 Q12809 1/20 0.33
CYP3A4 P08684 5/20 0.32
CYP2C9 P11712 5/20 0.32
CYP2C19 P33261 5/20 0.32
CYP2D6 P10635 2/20 0.32
CYP1A2 P05177 2/20 0.32
EP300 Q09472 2/20 0.32
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32
SCN3A Q9NY46 2/20 0.32
SCN9A Q15858 1/20 0.32
KCNQ2 O43526 1/20 0.32
SLC2A1 P11166 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL895804 0.87 KCNH2 (0.42) STAT3ALDH1A1GAAKCNH2CYP3A4
SCHEMBL895802 0.87 KCNH2 (0.42) STAT3ALDH1A1GAAKCNH2CYP3A4
SCHEMBL16309238 0.82 STAT3 (0.39) STAT3ALDH1A1GAAKCNH2CYP3A4
SCHEMBL896081 0.81 KCNH2 (0.39) PSMB8ALDH1A1KCNH2CYP3A4CYP2C9
SCHEMBL896062 0.81 F2 (0.43) ALDH1A1KCNH2CYP3A4CYP2C9CYP2C19
SCHEMBL894831 0.80 KCNH2 (0.45) ALDH1A1GAAKCNH2CYP3A4CYP2C9
SCHEMBL16309207 0.79 KCNH2 (0.49) ALDH1A1GAAKCNH2CYP3A4CYP2C9
SCHEMBL895147 0.79 KCNH2 (0.37) ALDH1A1KCNH2CYP3A4CYP2C9CYP2C19
SCHEMBL895420 0.78 KCNH2 (0.38) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL894832 0.73 KCNH2 (0.39) ALDH1A1GAAKCNH2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150246917-A1 INHIBITORS OF HEPATITIS C VIRUS REPLICATION MERCK SHARP & DOHME CORP. (US) 2015-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150246917-A1 INHIBITORS OF HEPATITIS C VIRUS REPLICATION HAVCR2, HCCS, EIF2AK2 PSMB8 985/4885PFKFB2 3322/4885PFKFB1 2986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.